Bacillus Calmette-Guerin alleviates airway inflammation and remodeling by preventing TGF-β1 induced epithelial-mesenchymal transition
Bacillus Calmette-Guerin (BCG) is a potent agent for the prevention of tuberculosis. Current studies have regarded BCG as an immunomodulator. However, there is little information on whether it can be used to inhibit airway inflammation and airway remodeling caused by asthma. Therefore, in this study...
Saved in:
Main Authors: | Xinrui Tian (Author), Xinli Tian (Author), Rujie Huo (Author), Qin Chang (Author), Guoping Zheng (Author), Yan Du (Author), Yan Chen (Author), Bo Niu (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2017-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical Course of Bacillus Calmette-Guerin Lymphadenitis
by: Dayoung Ko, et al.
Published: (2022) -
Sternal osteomyelitis after bacillus Calmette-Guérin vaccination
by: Rolandas Selvestravičius, et al.
Published: (2016) -
The management and outcome of Bacillus Calmette-Guérin vaccine overdose
by: Sung-Hsi Wei, et al.
Published: (2018) -
Intravescical instillation of Calmette-Guérin bacillus and COVID-19 risk
by: Ugo Fedeli, et al.
Published: (2021) -
Safety profiles of intravesical Bacillus Calmette-Guerin in bladder cancer
by: Yun Peng, et al.
Published: (2024)